BioPortfolio - Roche medecine company
Roche medecine company - BioPortfolio. ... Recent Search Terms used to find this page: Roche medecine company | roche 1507 | 1507 Roche Drug . ...
http://www.bioportfolio.com/search/Roche__medecine_company.h...
|
Roche setzte in den ersten neun Monaten 2008 das zweistellige ...
21 Oct 2008 ... Roche posts sustained double-digit sales growth for the first nine months ... Roche anticipates a high single-digit increase in Group sales, ...
http://www.roche.com/med-cor-2008-10-21-e.pdf...
|
BioPortfolio - Roche
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 1507 individuals from Roche using
...
http://www.bioportfolio.com/biocorporate/8981-Roche.html...
|
Roche: Building on strength Q3 '08: Analyst call October 21, 2008
that Roche’s earnings or earnings per share for this year or any ... Roche reaffirms commitment to Genentech offer and a negotiated agreement ..... 1507
...
http://www.roche.com/irp3q08e.pdf...
|
BioPortfolio - aminodextran
1507 Roche Drug | roche | roche factor Xa PAGE | Roche | parafrag drug design | David M. Goldstein Roche Palo Alto | roche | roche | aminodextran | . ...
http://www.bioportfolio.com/search/aminodextran.html...
|
Roche Annual Report 2006 - Finance Report
This control is normally evidenced when Roche Holding Ltd owns, either directly or ...... 1507. 1284. 1917. 1588. 190. 184. Other segment information ...
http://www.roche.com/fb06e.pdf...
|
Exit Goldman, Enter Roche: Can LBJ and Intellectua...[Science ...
1966 Sep 23;153(3743):1505-1507. Click here to read Links. Exit Goldman, Enter Roche: Can LBJ and Intellectuals Be Friends? ...
http://www.ncbi.nlm.nih.gov/pubmed/17749728...
|
2008 2007 % change January – September CHF m CHF m In CHF In local ...
1507 ... Roche Pharmaceuticals, Genentech and Chugai combined. 2. versus YTD September 2007 ... Roche Pharmaceuticals and Genentech combined ...
http://www.roche.com/mr3q08ane.pdf...
|
Monoclonal antibodies against components of the IGF system for ...
R-1507 (Roche Holding AG). R-1507 is a fully human κ-IgG1 and specifically inhibits. IGF-IR signaling. R-1507 was selected from a panel of ...
http://www.biomedcentral.com/content/pdf/cd-877268.pdf...
|
1) Cover Sheet
122, Capital and reserves attributable to Roche shareholders, 39444, 33334 .... 35, Additions to property, plant and equipment, 1091, 923, 1749, 1507 ...
http://www.roche.com/gb06fde.xls...
|
